Copyright
©The Author(s) 2019.
World J Diabetes. Feb 15, 2019; 10(2): 96-113
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.96
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.96
GRADE criteria | Rating | Support for judgement | Overall quality of evidence |
Outcome: Long term glycemic control (n = 14 studies) | |||
RoB (assessed on Cochrane RoB Collaboration Tool) | No | Only one study had low RoB for all categories. Most studies had at least one item at high or unclear RoB | High |
Serious (-1)1 | |||
Very serious (-2) | |||
Inconsistency | No | Generally, positive clinical effects demonstrated but some studies indicate null effects. There are also large variations in magnitude of effect. Heterogeneity is notable between the studies (in population, intervention and outcome assessment) | Moderate |
Serious (-1) 1 | |||
Very serious (-2) | |||
Indirectness | No1 | Evidence synthesized from studies addresses review question with respect to population, interventions and outcome | Low1 |
Serious (-1) | |||
Very serious (-2) | |||
Imprecision | No | All studies have groups with small sample sizes (≤ 20), with no indication that they meet required sample sizes to detect difference in outcome; observable but statistically insignificant measures in many studies suggest sample sizes were too small to detect difference. 95% confidence intervals of effect size estimates mostly suggest an appreciable benefit for treatment, but there are several that suggest possibility of no meaningful effect | Very low |
Serious (-1) | |||
Very serious (-2) 1 | |||
Publication bias | Undetected1 | There is chance of publication bias considering the review is entirely “small-scale” trials; this area of research is not well-established and there is potential for publication bias, but none was overtly detected | |
Strongly suspected (-1) | |||
Other | Large effect (+11 or +2) | Standardized mean difference of studies (effect size) indicates large magnitude of effect of treatment. Dose-response relationships observed | |
Dose response (+11 or +2) | |||
No plausible confounding (+1 or +2) |
- Citation: Omer K, Gelkopf MJ, Newton G. Effectiveness of royal jelly supplementation in glycemic regulation: A systematic review. World J Diabetes 2019; 10(2): 96-113
- URL: https://www.wjgnet.com/1948-9358/full/v10/i2/96.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i2.96